Related Experiment Video
Updated: Dec 17, 2025

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
Published on: June 7, 2017
Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer
Alessio Ugolini1, Vladimir A Tyurin2, Yulia Y Tyurina2
1Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania, USA.
Abstract:
DCs are a critical component of immune responses in cancer primarily due to their ability to cross-present tumor-associated antigens. Cross-presentation by DCs in cancer is impaired, which may represent one of the obstacles for the success of cancer immunotherapies. Here, we report that polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) blocked cross-presentation by DCs without affecting direct presentation of antigens by these cells. This effect did not require direct cell-cell contact and was associated with transfer of lipids. Neutrophils (PMN) and PMN-MDSC transferred lipid to DCs equally well; however, PMN did not affect DC cross-presentation. PMN-MDSC generate oxidatively truncated lipids previously shown to be involved in impaired cross-presentation by DCs. Accumulation of oxidized lipids in PMN-MDSC was dependent on myeloperoxidase (MPO). MPO-deficient PMN-MDSC did not affect cross-presentation by DCs. Cross-presentation of tumor-associated antigens in vivo by DCs was improved in MDSC-depleted or tumor-bearing MPO-KO mice. Pharmacological inhibition of MPO in combination with checkpoint blockade reduced tumor progression in different tumor models. These data suggest MPO-driven lipid peroxidation in PMN-MDSC as a possible non-cell autonomous mechanism of inhibition of antigen cross-presentation by DCs and propose MPO as potential therapeutic target to enhance the efficacy of current immunotherapies for patients with cancer.
Insights
Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) impair cancer immunity by blocking antigen cross-presentation in dendritic cells (DCs). Myeloperoxidase (MPO) drives this inhibition, suggesting MPO as a therapeutic target for cancer immunotherapy.
Area of Science:
- Immunology
- Cancer Biology
- Biochemistry
Background:
- Dendritic cells (DCs) are crucial for anti-cancer immunity via antigen cross-presentation.
- Impaired DC cross-presentation is a major hurdle for effective cancer immunotherapy.
- Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are implicated in immune suppression within the tumor microenvironment.
Purpose of the Study:
- To investigate the mechanism by which PMN-MDSC inhibit DC cross-presentation.
- To identify key molecular players involved in PMN-MDSC-mediated suppression.
- To explore the therapeutic potential of targeting PMN-MDSC in cancer immunotherapy.
Main Methods:
- Assessing DC antigen cross-presentation in the presence of PMN-MDSC.
- Investigating lipid transfer between PMN-MDSC and DCs.
- Utilizing myeloperoxidase (MPO)-deficient models and pharmacological MPO inhibition.
- Evaluating tumor progression in response to MPO inhibition combined with checkpoint blockade.
Main Results:
- PMN-MDSC, but not neutrophils (PMN), significantly impaired DC cross-presentation without affecting direct antigen presentation.
- This inhibition was mediated by lipid transfer from PMN-MDSC to DCs.
- MPO activity in PMN-MDSC was essential for generating oxidized lipids that block cross-presentation.
- MPO deficiency or pharmacological inhibition enhanced DC cross-presentation in vivo and improved anti-tumor responses when combined with checkpoint inhibitors.
Conclusions:
- MPO-driven lipid peroxidation in PMN-MDSC represents a non-cell autonomous mechanism suppressing DC cross-presentation.
- Targeting MPO in PMN-MDSC offers a promising strategy to overcome immune suppression and enhance cancer immunotherapy efficacy.
More Related Videos
14:15Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS
Published on: June 18, 2012
10:04Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
Related Concept Videos
Abnormal Proliferation
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Cell-mediated Immune Responses
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...